All times are in Eastern Time unless otherwise noted.

Loading Events

« All Events

Virtual Event Virtual Event
  • This event has passed.

Advocacy Panel Discussion: Federal Level Advocacy

November 12 @ 8:00 pm–9:00 pm EST

Virtual Event Virtual Event

đź“… Session Date: Tuesday, November 12, 2024

⏰ Time:
8:00 – 9:00 pm ET / 5:00 – 6:00 pm PT

đź’» Live Stream:
Register Today and reserve your spot!


Session Title:

Federal Advocacy Panel Discussion

Session Description:

Join us for an engaging and insightful panel discussion as part of our three-part speaker series tailored for healthcare providers-in-training. This session dives into federal advocacy, examining pathways to influence policy in the pharmaceutical, legal, and literary fields. If you’re a medical student or early-career healthcare professional looking to amplify your voice in public health, this session offers a unique opportunity to learn how to engage effectively at the federal level.

Why Attend?

This session is designed to empower future healthcare leaders with essential advocacy skills, expanding their capacity to drive meaningful change within healthcare policy. Gain practical insights and strategies to make a lasting impact as a healthcare provider in public advocacy.


Session Takeaways:

  • Collaborative Strategies: Learn effective ways to partner with legal experts as a healthcare professional.
  • Advocacy Pathways: Discover diverse advocacy methods and how to integrate them into your career.
  • Federal Engagement: Find out how you can participate in federal advocacy efforts even while still in training.

Featured Speakers:

  • Dr. Reshma Ramachandran, MD, MPP, MHS
    Chair, FDA Task Force
  • Dr. Cedric Dark, MD
  • Alyssa Morrison, JD

Don’t miss this opportunity to learn directly from leaders in healthcare advocacy!
Register Now!

Speaker: Dr. Reshma Ramachandran, MD, MPP, MHS

Reshma Ramachandran, MD, MPP, MHS is an Assistant Professor, board-certified family physician, and health services researcher. Her research focuses on the realignment of incentives for healthcare stakeholders including pharmaceutical companies, hospitals, and universities towards prioritizing equitable patient access to safe, effective health technologies.

She co-directs the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, an interdisciplinary initiative aligning research on medical product evaluation, approval, and coverage with the goal of advancing policies that improve patient outcomes. Prior to this role, Reshma worked as research faculty as part of the Innovation + Design Enabling Access (IDEA) Initiative at the Johns Hopkins Bloomberg School of Public Health, where she focused on policies to address the global challenge of antimicrobial resistance and unaffordable access to prescription drugs.

Dr. Ramachandran trained in both medicine at the Alpert Medical School at Brown University and in public policy at the Harvard Kennedy School of Government. She completed her family medicine residency at Kaiser Permanente Los Angeles Medical Center and health services research and policy fellowship at the National Clinician Scholars Program at Yale. Previously, she served as the first PharmFree Fellow with the American Medical Student Association focused on removing the undue influence of pharmaceutical companies on prescribing behavior and medical education.

She currently chairs the FDA Task Force for Doctors for America. She also is the Board President of Universities Allied for Essential Medicines (UAEM) North America.

Speaker: Dr. Cedric Dark, MD, MPH

Dr. Cedric Dark is an Associate Professor in the Henry J. N. Taub Department of Emergency Medicine at Baylor College of Medicine. He currently is on the Board of Directors for Doctors for America, the Board of Trustees for Semester at Sea, and is the Medical Editor-in-Chief for the monthly publication ACEP Now.

One of emergency medicine’s Top 45 Under 45 and on Elemental’s List of 50 Experts to Trust in a Pandemic, Dark is a trusted voice on health care and health policy. He has written numerous OpEds (Baltimore Sun, The Guardian, MedPage Today, Houston Chronicle, WIRED) and has given media interviews for print, radio, and television including NPR, CNN, MSNBC, Fox News, and BBC World News.

When not saving lives at the bedside, Dr. Dark strives to save them through policy. His policy experience includes work for the United States House of Representatives, the Kaiser Family Foundation, and the 2020 Joe Biden Campaign.

Although he knows how to rescue a patient from the brink of death after suffering a gunshot wound, his first book Under The Gun: An ER Doctor’s Cure for America’s Gun Epidemic explores how we can save more Americans’ lives before the bullet leaves the gun.

Speaker: Alyssa Morrison, JD

Prior to joining L4GG (Lawyers for Good Government), Alyssa spent 5 years working in constitutional impact litigation at the federal level with the Constitutional Law Center for Muslims in America (CLCMA). In her role at CLCMA, Alyssa’s practice was focused on challenging racial and religious discrimination in federal trial and appellate courts across the country.

Alyssa is admitted to practice in the Second, Fourth, Fifth, Seventh, Ninth, and D.C. Circuit Courts of Appeal and is a member in good standing with the Texas State Bar. During law school, Alyssa was the recipient of the Judge Elmo B. Hunter Legal Clinic for Victims of Crimes Against Women scholarship, awarded for her work with asylum seekers and refugees at the Karnes City ICE Detention Center and as a student attorney with YMCA International Services. She holds a B.A. from Texas A&M University and a J.D. from SMU Dedman School of law.

Alyssa brings her passion for individual liberty and her experience in constitutional law and civil rights with her to L4GG.

Details

Date:
November 12
Time:
8:00 pm–9:00 pm EST

WINTER MEMBERSHIP SALE! Use code WINTER for 30% OFF membership!

Contribute to our work by making a tax-deductible donation to DFA!